Vista-based orthopedic products maker DJO Global reported declines of 1 percent in sales and operating income in the first quarter due to the impact of a rising dollar on its foreign sales.
The company reported operating earnings of $59.0 million on sales of $280.1 million in its first fiscal quarter ended March 28. On a constant-currency basis, the company said, operating earnings grew 4 percent on a 5 percent increase in sales.
Shares of the privately-held company are no longer publicly traded, but the company continues to report sales and earnings.
“We are pleased to report strong top and bottom line performance, in line with expectations,” said Mike Mogul, DJO’s president and chief executive officer. “We also launched our Exprt Revision Knee, the world’s first orthopedic implant designed primarily for experienced surgeons providing a streamlined surgical experience at a much lower cost.”
“Just as exciting was our launch of the world’s first titanium knee brace, the A22, providing patients and athletes with a much lighter and lower profile experience in an ACL brace,” he said.
The company, founded in Carlsbad in 1978, is a leading developer, manufacturer and distributor of medical devices that provide solutions for musculoskeletal health, vascular health and pain management.
